Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. - Sakemura R; Hefazi M; Siegler EL; Cox MJ; Larson DP; Hansen MJ; Manriquez Roman C; Schick KJ; Can I; Tapper EE; Horvei P; Adada MM; et al. (Blood, 2022)